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The reactive airways dysfunction syndrome (RADS), the reactive upper airways dysfunction
syndrome (RUDS), the sick building syndrome (SBS), and the multiple chemical sensitivity
syndrome (MCS) are overlapping disorders in which there is an intolerance to environmental
chemicals. The onset of these illnesses is often associated with an initial acute chemical
exposure. To understand the pathophysiology of these conditions, a study of the nasal pathology
of individuals experiencing these syndromes was undertaken. Preliminary data indicate that the
nasal pathology of these disorders is characterized by defects in tight junctions between cells,
desquamation of the respiratory epithelium, glandular hyperplasia, lymphocytic infiltrates, and
peripheral nerve fiber proliferation. These findings suggest a model for a relationship between the
chronic inflammation seen in these conditions and an individual's sensitivity to chemicals. A
positive feedback loop is set up: the inflammatory response to low levels of chemical irritants is
enhanced due to the observed changes in the epithelium, and the epithelial changes are
propagated by the inflammatory response to the chemicals. This model, combined with the
concept of neurogenic switching, has the potential to explain many aspects of RADS, RUDS,
SBS, and MCS in a unified way. - Environ Health Perspect 105(Suppl 2):473-478 (1997)
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Introduction
That chemical exposures can produce
inflammation and that sensory nerves are
involved in this process have been recog-
nized since the early 1900s. In 1910 Bruce
demonstrated that the inflammatory
response to chemical irritants can be abol-
ished by ablation of sensory nerves (1).
This response is widely known. The red
eyes, nasal congestion, and sinus headaches
that arise from being stuck in the fumes of
rush-hour traffic, sitting in a smoky bar, or
painting with organic solvent-based paints
are examples of inflammation from expo-
sures to chemical irritants. This reactivity
to chemicals can be altered in some people,
and it is recognized that some people have
a heightened inflammatory response to
chemical irritants. A role for neurogenic
inflammation in chemical sensitivity has
been reviewed (2). This altered reactivity
to chemicals is best known in rhinitis and
asthma, with airway inflammation being
triggered by chemical irritants. Hence,
understanding chemical sensitivity in the
airway may hold the key to understanding
chemical sensitivity in general and the
multiple chemical sensitivity syndrome.
My colleagues and I propose to study
the nasal pathology of individuals with
allergic and chemical irritant rhinitis,
chemical sensitivity, and the multiple
chemical sensitivity syndrome. Many of us
believe, however, that chemical sensitivity
is a major public health problem that is
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related to the epidemics of inflammatory
conditions such as asthma and arthritis in
industrialized countries. Understanding the
asthma epidemic and understanding the
multiple chemical sensitivity syndrome may
be related, and the key to this process is
understanding how an acute chemical expo-
sure can produce ongoing inflammation in
the airway and at other sites.
Reactive airways dysfunction syndrome
(RADS) is a chronic asthmalike illness with
onset related to an acute chemical exposure
(3). Reactive upper airways dysfunction
syndrome (RUDS) is chronic rhinitis with
onset related to an acute chemical exposure
(4,5). The distinction between these syn-
dromes and the multiple chemical sensitiv-
ity syndrome (MCS) is that MCS patients
have symptoms at sites other than the air-
way. This paper updates the progress of
our nasal biopsy research program. Based
on biopsy specimens of individuals with
chemical sensitivity, a hypothetical model
has been developed of the process by which
an acute chemical exposure can lead to
chronic inflammation. In essence, a single
chemical exposure can induce a chronic
disease. After a few general comments, pre-
liminary biopsy findings and this model
will be presented.
General Comments
Chemical sensitivity to inhalants refers to
an abnormal sensitivity to a class of
inhalants that is different from allergy to
protein aeroallergens. Examples of this class
of inhalants are given in Table 1. A number
of case definitions have been given for
Table 1. Examples of inhalants associated with
chemical sensitivity.
Products of combustion
Cigarette and cigar smoke
Furnace fumes
Gas cook stove and water heater fumes
Wood smoke
Gasoline-powered vehicle exhaust
Diesel-powered vehicle exhaust
Kerosene heater exhaust
Perfumes and fragrances
Perfumes
Detergents (grocery store soap aisle syndrome)
Products for cleaning
Pesticides
Petrochemical derivatives
Solvents
Glues and adhesives
Fresh paint
Fresh printing ink
Building material outgassing
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chemical sensitivity syndromes (6), but
what is constant throughout all descriptions
is the inhalants involved. These inhalants
are often complex mixtures that are ubiqui-
tous in the environment of industrialized
countries. Typically, these inhalants contain
one or more odorous, low molecular weight,
volatile organic chemicals. They are toxins,
but the doses causing problems in chemi-
cally sensitive individuals are lower than the
doses associated with classic toxicity.
In the early descriptions of chemical
sensitivity, disease states associated with
inflammation were prominent. Randolph
described patients with arthritis, rhinitis,
asthma, inflammatory bowel disease, and
other inflammatory conditions that became
A
Respiratory epithelium
-------- -- Basement membrane
Glands
Sensory nerve fibers
B
Respiratory epithelium:
tight junction defects
and desquamation
-___---_-__-_-_----- Basement membrane:
thickening
" a Glands: hyperplasia
lymphocytic infiltrates
**/ Sensory nerve fibers:
A
proliferation
Figure 1. (A) Schematic of the elements of the normal
respiratory epithelium showing the epithelial cell layer
and the basement membrane. Glandular structures and
sensory nerves are found in the subepithelial tissue.
(B) Schematic of the deviations frorh normal seen in
biopsy specimens of persons developing chemical sen-
sitivity associated with rhinitis after a chemical expo-
sure (9). There are defects in the tight junctions
between respiratory epithelial cells, focal desquama-
tion of the epithelial cells in places, hypertrophy of
glandular structures, lymphocytic infiltrates, and prolif-
eration of sensory nerve fibers.
asymptomatic when patients were fasted on
spring water with control of both inhalants
and ingestants in an environmental control
unit (7). In addition, mental symptoms
such as hallucinations, depression, and
mania were described as improving when
these patients were removed from the chem-
ical environment. Elimination routines
included both inhalants and ingestants.
Symptoms were provoked by reexposure to
foods and chemicals.
It is natural to consider neurogenic
inflammation as a possible mechanism of
chemical sensitivity. For many decades it
has been known that sensory neurons are
involved in an inflammatory process, and
that this neurogenic inflammation is trig-
gered by chemicals that stimulate these
sensory neurons. For most people, these
reactions are mild and fleeting and are
resolved with the individual's removal to
fresh air. For some people, exposures such
as these can trigger debilitating illness with
reactions lasting several days.
The work of Bascom and her collabora-
tors is significant. A physiological response
to inhalant chemicals was demonstrated
in challenge studies with environmental
tobacco smoke (ETS). As Bascom pointed
out, this response is consistent with neuro-
genic inflammation (8).
My research in this area began when
patients with chemical sensitivity were
referred to an allergy clinic. These patients
complained of an intolerance to chemicals
associated with exposures to solvents or pes-
ticides. Physical examination, particularly
when supplemented with fiberoptic rhino-
laryngoscopy, revealed severe inflammation
of the upper airway in these patients.
Findings included edema, abnormal mucus,
cobblestoning (lymphoid hyperplasia), and
friability of the mucosa. One puzzling find-
ing that we consistently saw was focal areas
of white mucosa with prominent blood ves-
sels (4). Initially we thought this might
represent atrophy of the mucosa, but biop-
sies performed for clinical diagnosis in
selected patients revealed no atrophy, and
no difference between the white and red
areas of the mucosa. To our surprise, there
was chronic inflammation of the mucosa
with lymphocytic infiltrates in the biopsy
specimens. A preliminary research study
with controls was undertaken. The picture
that is emerging is depicted schematically in
Figure 1. Figure 1A is a schematic of the
anatomy of normal respiratory epithelium.
Abnormalities of the nasal mucosa sug-
gested by this study were lymphocytic infil-
trates, glandular hyperplasia, proliferation
of peripheral nerve fibers, gaps in the tight
Figure 2. The nasal mucosa from a subject with chemical sensitivity associated with rhinitis is shown in an elec-
tron micrograph. Three epithelial cells are seen on the right with defects in the tight junctions between the cells.
To the left, there is desquamation of the epithelial cell layer. The basement membrane appears to be thickened.
Environmental Health Perspectives * Vol 105, Supplement 2 * March 1997
..... ..... .....
...
474
PATHOLOGY OF CHEMICAL SENSITIVITY
junctions between epithelial cells, and focal
areas of desquamation of the epithelium (9).
These abnormalities are depicted schemati-
cally in Figure 1B. An example of an elec-
tron micrograph of a patient is shown in
Figure 2, with defects in tight junctions
between respiratory epithelial cells and
desquamation of epithelial cells visible.
Attempts to study the distribution of sub-
stance P and vasoactive intestinal poly-
peptide (VIP) in these specimens with
immunoperoxidase stains specific for these
substances were unsuccessful because cur-
rently available reagents stain multiple sites
in tissue specimens in a nonspecific pattern.
In the study by Meggs et al. (9), the
presence of inflammation in patients rela-
tive to controls was statistically significant
(p<O.05). This study did not have the
power to verify statistically the nerve fiber
proliferation that was seen in chemically
sensitive subjects relative to that in controls.
The challenge studies of Bascom et al.
and Willes et al. (8,10) and these biopsy
studies are complementary and supported
by other evidence that airway inflamma-
tion is involved in chemical sensitivity. In a
controlled study of patients with chemical
sensitivity, Doty et al. (11) found signifi-
cant increases in airway resistance in the
chemically sensitive group. Welch (12)
found significant exacerbations of preexist-
ing allergic disease and new onset of
asthma in patients with chemical sensitivity
developing in association with carpet
installation. Witorsch et al. (13) found that
100% of 61 patients meeting the Cullen
criteria for the multiple chemical sensitivity
syndrome had respiratory symptoms.
Meggs and Cleveland (4) found that 100%
of 10 consecutive patients referred to an
allergy clinic with complaints of chemical
sensitivity, all ofwhom met the Cullen cri-
teria, had severe inflammation demon-
strated by fiber optic rhinoscopy even if
they denied upper respiratory symptoms.
It is easy to understand how chemical
irritants trigger inflammation in the airway,
and in fact the majority of patients with
asthma and rhinitis report exacerbations
related to these same irritants (14,15). In
asthma, associations have been verified for
perfume and tobacco smoke (14,16).
Bascom et al. and Willies et al. verify an
association between ETS and an inflamma-
tory response in the upper airway (8,10).
Neurogenic Switching
How is it possible that stimulation of
respiratory receptors by airborne chemicals
can lead to involvement of other organ
systems? It has been pointed out that this
site switching is well known in allergic
diseases (17). Food allergy can trigger urti-
caria, rhinitis, and asthma. Ingestion of
foods or drugs as well as cutaneous inocu-
lation with vespid venom can trigger sys-
temic anaphylaxis. In experimental models
of anaphylaxis, ablation of neuronal path-
ways eliminates the anaphylactic response
without blocking histamine release or anti-
body production (18,19). This switching
of the site of inflammation in allergy and
chemical sensitivity may be due to the
same mechanism: there are neuronal path-
ways from the site of stimulation through
the central nervous system to other periph-
eral locations. This mechanism of site
switching has been termed neurogenic
A
40 Mast coll
_ _~
.A
_ _lkh
c
'A
_ _~~~~MOP
Effector cell
switching (17). The pathways involved as
well as the relationship between neurogenic
inflammation and allergic inflammation
are depicted in Figure 3. Table 2 character-
izes allergic rhinitis, arising from mast cell
degranulation in the upper airway as seen
at Site B in Figure 3, and chemical irritant
rhinitis, arising from substance P release
from the sensory nerves, as shown at Site A
in Figure 3.
Mechanism of Acquired
Chemical Sensitivity
Biopsy findings suggest a mechanism by
which an acute high-dose chemical expo-
sure can lead to permanent airway inflam-
mation and chemical sensitivity. The
sensory nerve fibers that react to chemical
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Figure 3. The relationship between allergic and immunogenic inflammation is depicted, with a proposed common
mechanism for the site switching from the site of stimulation to a distal site of inflammation. At site A, chemical
irritants, Ch, interact with sensory nerve fibers to trigger release of substance P, Sp, and other mediators of neuro-
genic inflammation. At site B, antigens, Ag, are depicted interacting with antibody on mast cells to release hista-
mine, H, and other mediators of allergic inflammation. Histamine interacts with nerve fibers to produce signal
transmission to the central nervous system. Site C depicts these mediators acting on effector cells to produce an
inflammatory response. Site D depicts inflammation being triggered at a site distant from the stimuli. Signals from
A or B are rerouted through the central nervous system to site D, where substance P, Sp, is released from the
nerve endings to initiate an inflammatory response.
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Table 2. Characterization of allergic rhinitis and chemical irritant rhinitis.
Allergic rhinitis Chemical irritant rhinitis
Trigger Protein aeroallergens Chemical inhalants
Target cell Mast cell Sensory nerve cell
Mediator released Histamine Substance P
Recruited cell Eosinophil Lymphocyte
Sensation Itching Burning
Symptoms Rhinorrhea Congestion
Sneezing Headache
irritants to produce inflammation are
located beneath the epithelial cell layer, as
seen in Figure 1. This cell layer acts as a
barrier between chemicals in the airway and
the nerve cells. It is reasonable to assume
that a high-dose exposure can penetrate this
barrier to trigger inflammation and can also
damage this layer so that there is a loss of
the epithelial layer. When the epithelial
barrier is lost, neurogenic inflammation
may be triggered at much lower doses.
Hence, there is ongoing inflammation,
which in turn continues the damage to the
epithelial barrier. A proliferation of nerve
fibers would mean that there are more
receptors for chemical irritants and more
inflammatory mediators to be released. The
integrity of the tight junctions between
epithelial cells is lost, and tumor necrosis
factor is known to produce similar defects
in tight junction integrity. One form of
tumor necrosis factor is produced by lym-
phocytes, and lymphocytic infiltrates are
seen in this patient population.
In summary, a positive feedback loop
may come into play, with epithelial dam-
age leading to a lower threshold at which
chemicals produce inflammation. This
inflammation in turn leads to ongoing loss
of integrity of the epithelium. This feedback
loop is depicted schematically in Figure 4.
Another factor that may come into play is
that lymphocytes may have specific antigen
receptors for chemicals; this occurs in con-
tact dermatitis. The details of the proposed
mechanism are depicted schematically in
Figure 5. Dotted lines indicate relationships
that are at this time suggested by data but
not rigorously established.
The proliferation of peripheral nerve
fibers described here has been seen in other
instances of inflammatory response and is
termed remodeling (20). This remodeling
effect may be produced by nerve growth
factor activity, and it is known that
lymphocytes have this activity (21).
Relationships between
RADS, RUDS, and MCS
Three of the possible scenarios for the
relationships between RADS, RUDS, and
MCS are shown in Figure 6. If these disor-
ders are separate, i.e., no relationships, one
might see some incidental overlaps due to
unfortunate individuals who may have two
or all three of these disorders (Figure 6A).
Another scenario is depicted in Figure 6B,
which suggests that RADS and RUDS are
subsets of MCS. These patients would have
MCS but have airway inflammation as a
very prominent component of their disease.
RADS is depicted as a subset of RUDS
because patients with lower airway inflam-
mation generally have some degree of upper
airway inflammation. Figure 6C depicts the
possibility that RUDS and MCS are the
same disorder, with the primary lesion being
upper airway inflammation and symptoms
in other organ systems arising from neuro-
genic switching. Figure 6C is the scenario
that is most consistent with my clinical
experience. The patients I have seen with
MCS, even those with predominantly men-
tal symptoms and no complaints of rhinitis,
have inflammation of the upper airway on
physical examination. The patients I have
seen with both RADS and RUDS all
reported symptoms involving other organ
systems related to chemical exposures, and
all meet case definitions for MCS.
Pathogenesis of
Inflammatory Conditions
of Unknown Etiology
Does the mechanism proposed here play a
role in conditions such as rheumatoid
arthritis, inflammatory bowel disease, and
migraine headache? Can chemicals in the
airway enhance these disease states by
switching the site of inflammation from the
airway to other sites? Perhaps the patho-
physiology of these conditions involves
establishing neuronal pathways to the sites
of recurrent inflammation. Multiple stimuli
Figure 4. Proposed mechanism used to induce a high-
dose chemical exposure to lead to sensitivity to low-
level chemical exposures via epithelial damage. A
positive feedback loop is created in which ongoing
low-level exposures perpetuate epithelial damage,
which in turn leads to a lower threshold at which
chemicals will damage the epithelium.
Figure 5. Details of the proposed mechanism for ongoing inflammation and chemical sensitivity following an
inducing high-dose chemical exposure. Dotted arrows show relationships that are speculative and warrant further
investigation.
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Figure 6. Venn diagrams depicting possible relation-
ships between RADS, RUDS, and MCS.
such as chemicals in the airway, infections,
allergies, and emotional stress could result
in excitation of these pathways.
Research Needs
Much work is still to be done on this
model, as summarized in Table 3. Basic
science needs include the elucidation of the
chemoreceptors on the sensory nerves.
These receptors are thought to be proteins
on the sensory nerve membranes and need
to be isolated so they can be sequenced and
have their structures studied. Clinically,
there is a specificity to the response to
chemicals. Some patients with severe
chemical sensitivities have been known to
tolerate substances that are devastating to
others. For example, not all patients with
asthma are aversely affected by exposure to
Table 3. Basic science and clinical research needs.
Basic science needs
Isolate chemoreceptors
Sequence chemoreceptors
Study structure of chemoreceptors
Study mechanism of chemical specificity-
chemoreceptors vs lymphocytes
Study mechanism of nerve fiber proliferation
Determine role of tumor necrosis factor
Study the neurological pathways of neurogenic
switching
Clinical science needs
Conduct further biopsy studies in RADS, RUDS,
MCS, SBS
Expand control groups
Develop experimental models of the induction and
propagation of chemical sensitivity
Conduct challenge studies
Conduct studies of inflammatory conditions in
environmental control units
Study treatment of chemical sensitivity
cigarette smoke; however, it can be devas-
tating to other patients. Is there a chemore-
ceptor specificity, or does the specificity lie
with the lymphocytes? Chemical specific
receptors on lymphocytes are known to
occur in contact dermatitis, and a similar
situation may exist in the airway. What is
the mechanism of the peripheral nerve
fiber proliferation suggested in patients'
biopsies? Do lymphocytes or nerves pro-
duce a factor that causes this proliferation?
What is the mechanism by which gap junc-
tion integrity breaks down? Is tumor
necrosis factor involved in this process?
Clinical science needs include further
biopsy studies in both humans and other
species. Larger control groups are needed,
including normal subjects, patients with
allergic rhinitis and allergic asthma,
patients with asthma and rhinitis related to
chemical exposures, and chemically sensi-
tive patients without rhinitis. Biopsy
studies should be combined with challenge
studies to aid in assigning patients to
groups. The problem of nonspecific stain-
ing of monoclonal antibodies to substance
P, VIP, and neutral endopeptidase should
be addressed, and functional assays may
be necessary to establish the role of these
substances in chemical sensitivity.
The role of chemical sensitivity in
inflammatory conditions of unknown eti-
ology such as inflammatory bowel disease,
rheumatoid arthritis, and other collagen
vascular diseases should be elucidated. This
work can only be done in environmental
control units because adapatative phenom-
ena and masking are so prominent in these
populations under study.
Most importantly, clinical research must
be done to improve treatment of chemically
sensitive patients. Do anti-inflammatory
medications such as nonsteroidal anti-
inflammatory drugs and topical steroids
have roles in the treatment of chemical sen-
sitivity patients? Do the substance P
inhibitors now in clinical trial have roles in
the management of chemical sensitivity?
Does avoidance of chemical inhalants
reduce reactivity to chemical irritants? Does
the nasal epithelium heal if the patient is
removed from the chemical environment?
Does this healing result in the patient
having decreased reactivity to chemicals?
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